JO
CURX

John Overdeck’s Curanex Pharmaceuticals CURX Stock Holding History

John Overdeck’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25K Buy
1,368
+355
+35% +$2.58K ﹤0.01% 5010
2026
Q1 		$10.4K Sell
1,013
-2,042
-67% -$15.3K ﹤0.01% 4529
2025
Q4 		$20.2K Buy
+3,055
New +$33.6K ﹤0.01% 3998

Other funds holding CURX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

John Overdeck's CURX Position: Q2 2026 in Review

John Overdeck increased its Curanex Pharmaceuticals (CURX) stake by 35% in Q2 2026, buying an estimated $2.58K and bringing the position to 1,368 shares worth $7.25K. The position accounts for ﹤0.01% of the portfolio, ranked #5010.

John Overdeck first reported a position in CURX in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.2K in Q4 2025. 11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • John Overdeck held 1,368 shares of Curanex Pharmaceuticals worth $7.25K as of Q2 2026.
  • John Overdeck bought 355 Curanex Pharmaceuticals shares in Q2 2026, an estimated $2.58K.
  • Curanex Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #5010 holding.
  • John Overdeck first reported a position in Curanex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • John Overdeck's Curanex Pharmaceuticals position peaked at $20.2K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.